Boundless Enterprise Value Over E B I T D A from 2010 to 2024
| BOLD Stock | USD 10.00 0.10 1.01% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 0.39953895 | Current Value 0.42 | Quarterly Volatility 18.77133807 |
Check Boundless Bio, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boundless main balance sheet or income statement drivers, such as Depreciation And Amortization of 909.1 K, Selling General Administrative of 11.5 M or Other Operating Expenses of 55.2 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Boundless financial statements analysis is a perfect complement when working with Boundless Bio, Valuation or Volatility modules.
Boundless | Enterprise Value Over E B I T D A |
Latest Boundless Bio,'s Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Boundless Bio, Common over the last few years. It is Boundless Bio,'s Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Boundless Bio,'s overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Boundless Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (18.14) | |
| Geometric Mean | 7.77 | |
| Coefficient Of Variation | (103.49) | |
| Mean Deviation | 13.86 | |
| Median | (13.27) | |
| Standard Deviation | 18.77 | |
| Sample Variance | 352.36 | |
| Range | 53.2158 | |
| R-Value | (0.09) | |
| Mean Square Error | 376.48 | |
| R-Squared | 0.01 | |
| Significance | 0.75 | |
| Slope | (0.37) | |
| Total Sum of Squares | 4,933 |
Boundless Enterprise Value Over E B I T D A History
About Boundless Bio, Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Boundless Bio, income statement, its balance sheet, and the statement of cash flows. Boundless Bio, investors use historical funamental indicators, such as Boundless Bio,'s Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Boundless Bio, investors may use each financial statement separately, they are all related. The changes in Boundless Bio,'s assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Boundless Bio,'s income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Boundless Bio, Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Boundless Bio,. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 0.40 | 0.42 |
Pair Trading with Boundless Bio,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boundless Bio, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boundless Bio, will appreciate offsetting losses from the drop in the long position's value.Moving against Boundless Stock
| 0.47 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.45 | VCYT | Veracyte | PairCorr |
| 0.44 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.44 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.42 | VCNX | Vaccinex | PairCorr |
The ability to find closely correlated positions to Boundless Bio, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boundless Bio, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boundless Bio, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boundless Bio, Common to buy it.
The correlation of Boundless Bio, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boundless Bio, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boundless Bio, Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Boundless Bio, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Boundless Bio, Correlation against competitors. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Boundless Stock analysis
When running Boundless Bio,'s price analysis, check to measure Boundless Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio, is operating at the current time. Most of Boundless Bio,'s value examination focuses on studying past and present price action to predict the probability of Boundless Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio,'s price. Additionally, you may evaluate how the addition of Boundless Bio, to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Boundless Bio,'s industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio,. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.33) | Return On Equity (0.53) |
The market value of Boundless Bio, Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio,'s market value can be influenced by many factors that don't directly affect Boundless Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boundless Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.